The company has secured $410m in an oversubscribed Series A funding round, co-led by Forbion and General Atlantic, with contributions from investors such as RA Capital Management, OrbiMed ...

Forbion and General Atlantic led the financing, with participation from RA Capital Management, OrbiMed, Logos Capital ... the same GLP-1 class as Novo’s Wegovy and Lilly’s Zepbound that ...

London-based Verdiva Bio has launched with $411 million in series A funding, becoming the latest biotechnology firm to seek weight-loss drug opportunities. The start-up expects to advance its lead ...

The company has secured $410m in an oversubscribed Series A funding round, co-led by Forbion and General Atlantic, with contributions from investors such as RA Capital Management, OrbiMed, Logos ...

Now, a new study finds that Ozempic, along with similar drugs such as Wegovy, has had a broad “economic and societal impact” because of “noticeable shifts in dietary behavior.” The study ...

The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...

"What this does is it takes away that signal. It is a miracle drug." GLP-1 agonist drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, can help with weight loss by mimicking at least one ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

The Bulletin of the Atomic Scientists set the Doomsday Clock to 89 seconds to midnight, one second more than the last two years, attributed to threats posed by climate change and artificial ...